Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
Return to Top
Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.
Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid. J Manag Care Spec Pharm. 2018 Jul; 24(7):664-676.
View in:
PubMed
subject areas
Administrative Claims, Healthcare
Administrative Claims, Healthcare
Adult
Adult
Antiviral Agents
Antiviral Agents
Cohort Studies
Cohort Studies
Cost of Illness
Cost of Illness
Cross-Sectional Studies
Cross-Sectional Studies
Drug Costs
Drug Costs
Drug Therapy, Combination
Drug Therapy, Combination
Female
Female
Genotype
Genotype
Hepacivirus
Hepacivirus
Hepatitis C, Chronic
Hepatitis C, Chronic
Humans
Humans
Liver Cirrhosis
Liver Cirrhosis
Male
Male
Medicaid
Medicaid
Middle Aged
Middle Aged
Oklahoma
Oklahoma
Pharmaceutical Services
Pharmaceutical Services
Sustained Virologic Response
Sustained Virologic Response
Treatment Failure
Treatment Failure
United States
United States
authors with profiles
Robert C Rathbun
Grant H Skrepnek